Blank paper box mockup, white box template for design uses in 3d illustration
NINTEDANIB/STADA
FORM
Soft capsules
STRENGTH
100 & 150 mg
INDICATIONS
Nintedanib/STADA is indicated in adults for the treatment of idiopathic pulmonary fibrosis (IPF).
Nintedanib/STADA is also indicated in adults for the treatment of other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype (see section 5.1).
Nintedanib/STADA is indicated in adults for the treatment of systemic sclerosis associated interstitial lung disease (SSc-ILD).
Important note
Treatment should be initiated by physicians experienced in the management of diseases for which Nintedanib/STADA is approved.
